Dana Pizzuti, Chief Med and Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 12,984 shares at $29.18 ($379K) on 2025-08-20, disclosed to the SEC on 2025-08-21.
Scheduled sale ($379k) by Chief Med and Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.18 | 6,492 | $189K | 50.0% |
| 2 | $29.18 | 6,492 | $189K | 50.0% |
| Total | $29.18 avg | 12,984 | $379K | 100% |
| Filing → |
| CRNX | SELL | 2025-10-03 | $209K | — | Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |